New Version of the HPRA GDP Guide Published
Recommendation
22 October 2026
Good Distribution Practice of Active Substances for Human and Veterinary Medicinal Products
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The Irish Health Products Regulatory Authority (HPRA) has released an updated version of its Guide to Good Distribution Practice of Medicinal Products for Human Use. Version 8 (document IA-G0046-8) was published in April.
The guide is intended to provide additional clarification to wholesalers and brokers located in Ireland regarding the EU GDP Guidelines (Guidelines of 5 November 2013 on Good Distribution Practice of Medicinal Products for Human Use - 2013/C 343/01).
A tracked-changes version of the document shows that, in addition to minor editorial edits, updates and additions have been made to the following sections:
- Supplier approval
- Sourcing of exempt medicinal products
- Verification of safety features
- Establishment of the authority of customers to receive medicinal products
- Decommissioning of unique identifiers prior to supply
The updated guide is available for download as a PDF file.
Related GMP News
30.09.2026European GDP Association Developments May through August 2026
30.09.2026Warehouse Temperature Excursions: What Does the FDA Expect?
30.09.2026Version 4.0 of the Swissmedic Document on Notifications of Changes Published
30.09.2026USA: Court Stops Warehouse Activities Following Persistent Insanitary Warehouse Conditions
30.09.2026GDP Non-Compliance Report: CAPA Measures must not only be Promised but also Implemented
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September